13-09-2026 22:45 via medpagetoday.com

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer

(MedPage Today) -- Two investigational anti-B7-H3 antibody-drug conjugates (ADCs) significantly improved survival outcomes in patients with relapsed small-cell lung cancer (SCLC), according to a pair of Chinese trials.
In the TAISHAN-302 study...
Read more »

Medical news



No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy
'A Real-but-Vanilla Commercial Dispute': What We Heard This Week
It's High Time for Operation 'Tick Speed'
Local Consolidative Therapy After Dual Immunotherapy Fizzles in Metastatic NSCLC
Bipartisan Campaign Pledges $100M to Cut U.S. Maternal Mortality Rate in Half
Predicting Preeclampsia With a Protein? Gene-Silencing for Cardiomyopathy
The CDC Division I Spent 15 Years Building Is in Peril
Parasite Infestation Common in Eyelash Extensions, Study Suggests
Menopausal Hormone Therapy May Ease Severe Mood Symptoms
False and Misleading Claims on Healthcare During the Republican Midterm Convention
Boycott of the American Diabetes Association Launched
'Emergency' Medical Kits Touted by Dr. Drew and Others Draw Criticism
Cancer Diagnosis, Then a Stroke; 9/11 Cancer Deaths; 'Grand Slam' Drug and Price
How Was Menopausal Hormone Therapy Linked to Heart Health?
Desktop versie